Skip to main content Skip to search Skip to main navigation
Fast Delivery
Easy Purchase
Modern Logistics
Extensive Portfolio
Reliability

Abbott NMP22 BladderChek rapid test (10 pcs.)

Product information "Abbott NMP22 BladderChek rapid test (10 pcs.)"

The NMP22® BladderChek® test is a quick, easy and non-invasive test that works in conjunction with conventional diagnostic methods to help detect and monitor bladder cancer. This is a quick and cost-effective aid in the detection of bladder cancer in at-risk patients. The test detects a nuclear matrix protein released from urothelial tumour cells. According to studies, the test has a sensitivity of > 82 % (up to 94 % depending on the tumour stage) and a specificity of 76 %. In combination with urine cytology, the sensitivity increases to almost 100 %. As the results are available at the point-of-care within 30 minutes, they can be communicated to the patients during the same visit to the doctor.

ABBOTT GmbH & Co. KG


Max-Planck-Ring 2
65205 Wiesbaden
info.de@abbott.com